Skip to main content
Synergy Innovation Co., Ltd. logo

Synergy Innovation Co., Ltd. — Investor Relations & Filings

Ticker · 048870 ISIN · KR7048870000 KO Manufacturing
Open in API
Filings indexed 321 across all filing types
Latest filing 2024-03-29 Board/Management Inform…
Country KR South Korea
Listing KO 048870

About Synergy Innovation Co., Ltd.

http://www.synergyinno.com/

Synergy Innovation Co., Ltd. is a company focused on the biotechnology sector, which it considers a primary growth engine. The company engages in research, development, and investment activities related to new and generic drugs, medical devices, and health functional foods. Its R&D efforts encompass areas such as genetics and the development of cell culture mediums. Synergy Innovation actively pursues growth through a combination of internal projects and strategic external investments to expand its portfolio.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled 'Report on the Appointment, Dismissal, or Resignation of Outside Directors' (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). It details specific changes to the company's board of directors, including the appointment of new outside directors and the resignation of an existing one. This falls directly under the category of announcements regarding changes in the company's board of directors or senior management.
2024-03-29 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Synergy Innovation) detailing the acquisition of shares in another company (Medica Korea). It follows the standard structure of a 'Major Corporate Disclosure' (DART filing) regarding the acquisition of equity securities in another corporation. This type of transaction is a corporate development activity that falls under the category of M&A activity or significant capital investment, which is best classified as 'TAR' (M&A Activity) within the provided schema.
2024-03-29 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 26th fiscal year (2023), covering the period from January 1, 2023, to December 31, 2023. It is addressed to the Financial Services Commission and the Korea Exchange. It contains comprehensive company information, including organizational structure, history, management changes, and business operations. This is a standard South Korean annual filing equivalent to a 10-K. FY 2023
2024-03-22 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Synergy Innovation. It provides the audit opinion (적정/Unqualified), financial highlights (assets, liabilities, equity, revenue, profit), and details regarding the auditor (동현회계법인). While it contains financial data, it is a standard regulatory disclosure form required by the KRX (Korea Exchange) to announce the receipt and submission of the audit report, rather than the full 10-K annual report document itself. Therefore, it is classified as an Audit Report/Information document. FY 2023
2024-03-21 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Synergy Innovation. It details the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation or voting. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2024-03-14 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated date' (a date when many companies hold their AGMs). It explains the rationale for choosing this date and acknowledges the company's participation status in the voluntary dispersion program. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2024-03-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.